Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies

By Proactive Investors / February 12, 2024 / www.youtube.com / Article Link


Poolbeg Pharma Plc chief business officer David Allmond joined Proactive's Stephen Gunnion with details of independent ...

Recent News

Mixed outlook for gold as it remains range bound for past three months
June 30, 2025 / www.canadianminingreport.com

Gold stocks down on flat metal price
June 30, 2025 / www.canadianminingreport.com

Gold stocks down on metal decline
June 23, 2025 / www.canadianminingreport.com

Huge quantifiable rise in geopolitical, economic and trade risks
June 23, 2025 / www.canadianminingreport.com

Platinum clearly ahead of palladium for first time in seven years
June 16, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok